Skip to content
10-Q

Quarterly Report

Vitae Pharmaceuticals, Inc

0001104659-16-119755

← back to feed
Filed
May 10, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 4, 2016 28.84M sh
Stock Issued Q1 2016 · Mar 31, 2016 6.65M sh
Shares Diluted Q1 2016 · Mar 31, 2016 22.54M sh
Shares Diluted Q1 2016 · Mar 31, 2015 20.83M sh
Capex Q1 2016 · Mar 31, 2016 $22.33K
Capex Q1 2016 · Mar 31, 2015 $63.01K
Cash And Equivalents Q1 2016 · Mar 31, 2016 $58.35M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $11.77M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $12.48M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $29.49M
Stockholders Equity Q1 2016 · Mar 31, 2016 $82.49M
Stockholders Equity Q1 2016 · Dec 31, 2015 $54.47M
Current Liabilities Q1 2016 · Mar 31, 2016 $5.8M
Current Liabilities Q1 2016 · Dec 31, 2015 $7.33M
Total Liabilities Q1 2016 · Mar 31, 2016 $5.84M
Total Liabilities Q1 2016 · Dec 31, 2015 $7.38M
Current Assets Q1 2016 · Mar 31, 2016 $87.66M
Current Assets Q1 2016 · Dec 31, 2015 $61.14M
Total Assets Q1 2016 · Mar 31, 2016 $88.33M
Total Assets Q1 2016 · Dec 31, 2015 $61.85M
Eps Diluted Q1 2016 · Mar 31, 2016 −$0.44
Eps Diluted Q1 2016 · Mar 31, 2015 −$0.47
Eps Basic Q1 2016 · Mar 31, 2016 −$0.44
Eps Basic Q1 2016 · Mar 31, 2015 −$0.47
Sga Expense Q1 2016 · Mar 31, 2016 $2.5M
Sga Expense Q1 2016 · Mar 31, 2015 $2.11M
Rd Expense Q1 2016 · Mar 31, 2016 $7.64M
Rd Expense Q1 2016 · Mar 31, 2015 $7.51M
Net Income Q1 2016 · Mar 31, 2016 −$10.01M
Net Income Q1 2016 · Mar 31, 2015 −$9.71M
Operating Income Q1 2016 · Mar 31, 2016 −$10.08M
Operating Income Q1 2016 · Mar 31, 2015 −$9.47M
Revenue Q1 2016 · Mar 31, 2016 $51.35K
Revenue Q1 2016 · Mar 31, 2015 $150.24K